DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Spirorenone
Spirorenone
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
1 Serendipitous Target-Based Drug Discoveries János Fischer and David P
(12) United States Patent (10) Patent No.: US 8,524,693 B2 Iglesias Retuerto Et Al
Bayer Inc. and Bayer Pharma Aktiengesellschaft V. Cobalt
Customs Tariff - Schedule
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Drospirenone: Pharmacology and Pharmacokinetics of a Unique Progestogen
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Over the Last Twenty Years, Plaintiff's Corporate Ownership Has Changed. This Is Not an Issue Here. Throughout This Opinion
Pharmaabkommen A1 E
Tariffa Integrata Delle Comunità Europee (TARIC) Volume IV — Allegati (96/C 98 A/01 )
Top View
Customs Tariff - Schedule Xxi - 1
(12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Download Product Insert (PDF)
Janos Fischer-Serendipitous Target-Based Drug Discovery
Wo 2007/025780 A2
Spironolactone - Wikipedia
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
WO 2016/063269 Al 28 April 2016 (28.04.2016) P O P C T
Schedule Clxxiii - European Union
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
(12) Patent Application Publication (10) Pub. No.: US 2005/0207990 A1 Funke Et Al